News Focus
News Focus
Followers 968
Posts 387456
Boards Moderated 0
Alias Born 06/24/2011

Re: None

Sunday, 05/11/2025 5:56:15 PM

Sunday, May 11, 2025 5:56:15 PM

Post# of 159
During the quarter, Cadrenal successfully completed the technical transfer and manufacturing of its tecarfarin drug substance (API) from a CDMO site located in Asia to a CDMO site in the United States. This initiative was done to support the company’s clinical and regulatory development strategy for tecarfarin and to improve supply chain security.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVKD News